8
Oct
2024

Samyang Holdings Corporation

Exhibitor at CPHI Milan 2024 stand 4C73, API
About Us

http://www.samyangbiopharm.com/eng

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Other
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Other
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4C73, API

Products Featured at CPHI Milan 2024

  • FPFs

    Product FPFs

    • Genexol®PM Inj.(Paclitaxel)   • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid...
  • APIs

    Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • CDMO

    Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S

Samyang Holdings Corporation Resources (1)